About : Assembly Bio

Passionate about making a profound impact on patients’ lives

Assembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic clinical candidates capable of improving the lives of millions living with chronic hepatitis B virus (HBV) infection around the world, and research programs focused on the discovery of additional novel antivirals to treat devastating viral diseases.

Focused on Transforming HBV Treatment

Assembly Bio’s team aspires to deliver finite and curative treatments for HBV, one of the world’s most prevalent and devastating infectious diseases.

Explore our HBV program.

Management Team

John McHutchison AO, MD

Chief Executive Officer & President, Director

William Delaney, PhD

Chief Scientific Officer

Chief Operating Officer

Chief Financial Officer

Luisa Stamm, MD, PhD

Chief Medical Officer

Chief Human Resources Officer

Nicole S. White

Chief Manufacturing Officer

Michele Anderson

Senior Vice President, Development Operations

Board of Directors

William Ringo

Chairman of the Board, Non-Executive

Anthony Altig

Director

Gina Consylman

Director

Richard DiMarchi, PhD

Director

Myron Z. Holubiak

Director

Sir Michael Houghton, PhD

Director

Lisa Johnson-Pratt, MD

Director

Sue Mahony, PhD

Director

John McHutchison AO, MD

Chief Executive Officer & President, Director

Scientific Advisory Board

Antonio Bertoletti, MD

Richard DiMarchi, PhD

Edward J. Gane, MBCHB, MD, FRACP, MNZM

Sir Michael Houghton, PhD

Patrick Kennedy, MB BCh BAO BMedSci FR CP MD

Prof Stephen Locarnini, BSc (Hons), PhD, MBBS, FRC (Path)

Alex Thompson, MBBS, PhD, FRACP

Stephan Urban, PhD

Adam Zlotnick, PhD

Fabien Zoulim, MD, PhD

Contact Us

CORPORATE HEADQUARTERS
331 Oyster Point Blvd.
4th Floor
South San Francisco, CA 94080

FOR GENERAL INFORMATION,
PLEASE CONTACT:
833.509.4583
info@assemblybio.com

FOR QUESTIONS ABOUT COLLABORATION
OPPORTUNITIES, PLEASE CONTACT:
BD@assemblybio.com